Precision Biosciences (DTIL) FCF Margin Growth (3y) (2021 - 2026)
Precision Biosciences (DTIL) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Precision Biosciences |
168.99 Mn |
67.81 Mn |
- |
25,399.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
25,399.00 |
| Dec 31, 2025 |
17,912.00 |
| Sep 30, 2025 |
-11.78 Mn |
| Jun 30, 2025 |
-11.20 Mn |
| Mar 31, 2025 |
-6.50 Mn |
| Dec 31, 2024 |
-254,626.00 |
| Sep 30, 2024 |
-93,066.00 |
| Jun 30, 2024 |
1,815.00 |
| Mar 31, 2024 |
-51,792.00 |
| Dec 31, 2023 |
4,515.00 |
| Sep 30, 2023 |
13,708.00 |
| Jun 30, 2023 |
244,676.00 |
| Mar 31, 2023 |
2,172.00 |
| Dec 31, 2022 |
18,789.00 |
| Sep 30, 2022 |
79,053.00 |
| Jun 30, 2022 |
-19,597.00 |
| Mar 31, 2022 |
-43,758.00 |
| Dec 31, 2021 |
6,388.00 |
| Sep 30, 2021 |
59,435.00 |
| Jun 30, 2021 |
50,899.00 |
